These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15734301)

  • 1. Correlation between the release characteristics of theophylline and the free volume of polyvinylpyrrolidone.
    Zelkó R; Süvegh K
    Eur J Pharm Sci; 2005 Mar; 24(4):351-4. PubMed ID: 15734301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the enthalpy recovery and free volume of polyvinylpyrrolidone during anomalous glassy to rubbery transition.
    Zelkó R; Süvegh K
    Eur J Pharm Sci; 2004 Mar; 21(4):519-23. PubMed ID: 14998583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracking of the physical ageing of amorphous pharmaceutical polymeric excipients by positron annihilation spectroscopy.
    Zelkó R; Orbán A; Süvegh K
    J Pharm Biomed Anal; 2006 Feb; 40(2):249-54. PubMed ID: 16143484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Processing-induced phase transitions of theophylline--implications on the dissolution of theophylline tablets.
    Tantry JS; Tank J; Suryanarayanan R
    J Pharm Sci; 2007 May; 96(5):1434-44. PubMed ID: 17455350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the stability of polymeric matrix tablets containing famotidine from the positron annihilation lifetime distributions of their physical mixtures.
    Szente V; Süvegh K; Marek T; Zelkó R
    J Pharm Biomed Anal; 2009 Apr; 49(3):711-4. PubMed ID: 19188038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
    Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
    Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of storage conditions on the free volume of polyvinylpyrrolidone: comparison of positron lifetime data with the tensile strength of tablets.
    Zelkó R; Süvegh K; Marton S; Rácz I
    Pharm Res; 2000 Aug; 17(8):1030-2. PubMed ID: 11028953
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the free volume and the metoprolol tartrate release of Metolose patches.
    Papp J; Szente V; Süvegh K; Zelkó R
    J Pharm Biomed Anal; 2010 Jan; 51(1):244-7. PubMed ID: 19647965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of storage conditions on the physical aging of amorphous polyvinylpyrrolidone].
    Zelkó R; Süvegh K
    Acta Pharm Hung; 2002; 72(2):123-6. PubMed ID: 12498039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silk fibroin as a novel coating material for controlled release of theophylline.
    Bayraktar O; Malay O; Ozgarip Y; Batigün A
    Eur J Pharm Biopharm; 2005 Aug; 60(3):373-81. PubMed ID: 15996578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline.
    Vendruscolo CW; Andreazza IF; Ganter JL; Ferrero C; Bresolin TM
    Int J Pharm; 2005 May; 296(1-2):1-11. PubMed ID: 15885450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of physical aging on the structural behavior of amorphous poly(vinylpyrrolidone) polymers].
    Zelkó R; Süvegh K
    Acta Pharm Hung; 2003; 73(1):46-50. PubMed ID: 12891899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of theophylline sustained release dosage form based on Kollidon SR.
    Reza MS; Quadir MA; Haider SS
    Pak J Pharm Sci; 2002 Jan; 15(1):63-70. PubMed ID: 16414869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of moisture on polyvinylpyrrolidone in accelerated stability testing.
    Fitzpatrick S; McCabe JF; Petts CR; Booth SW
    Int J Pharm; 2002 Oct; 246(1-2):143-51. PubMed ID: 12270617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.